ZhuZhou QianJin Pharmaceutical Co Ltd (600479) - Total Liabilities
Based on the latest financial reports, ZhuZhou QianJin Pharmaceutical Co Ltd (600479) has total liabilities worth CN¥1.66 Billion CNY (≈ $242.40 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore ZhuZhou QianJin Pharmaceutical Co Ltd cash flow conversion to assess how effectively this company generates cash.
ZhuZhou QianJin Pharmaceutical Co Ltd - Total Liabilities Trend (2001–2024)
This chart illustrates how ZhuZhou QianJin Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 600479 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
ZhuZhou QianJin Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of ZhuZhou QianJin Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
African Rainbow Capital Investments Ltd
JSE:AIL
|
South Africa | ZAC2.00 Million |
|
Atos SE
PA:ATO
|
France | €7.27 Billion |
|
Fujian Raynen Tech Co Ltd
SHG:603933
|
China | CN¥1.14 Billion |
|
Jiangxi Sanxin Medtec Co Ltd
SHE:300453
|
China | CN¥833.14 Million |
|
Compass Pathways Plc
NASDAQ:CMPS
|
USA | $218.02 Million |
|
Rpmglobal Holdings Ltd
AU:RUL
|
Australia | AU$48.30 Million |
|
Suzhou Tianwo Science and Technology Co Ltd
SHE:002564
|
China | CN¥5.26 Billion |
|
Canadian General Investments Ltd
TO:CGI
|
Canada | CA$202.17 Million |
Liability Composition Analysis (2001–2024)
This chart breaks down ZhuZhou QianJin Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ZhuZhou QianJin Pharmaceutical Co Ltd (600479) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.40 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.66 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.34 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ZhuZhou QianJin Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ZhuZhou QianJin Pharmaceutical Co Ltd (2001–2024)
The table below shows the annual total liabilities of ZhuZhou QianJin Pharmaceutical Co Ltd from 2001 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥1.42 Billion ≈ $207.37 Million |
-14.12% |
| 2023-12-31 | CN¥1.65 Billion ≈ $241.47 Million |
-8.62% |
| 2022-12-31 | CN¥1.81 Billion ≈ $264.23 Million |
+32.74% |
| 2021-12-31 | CN¥1.36 Billion ≈ $199.06 Million |
-7.26% |
| 2020-12-31 | CN¥1.47 Billion ≈ $214.63 Million |
+24.03% |
| 2019-12-31 | CN¥1.18 Billion ≈ $173.05 Million |
+13.44% |
| 2018-12-31 | CN¥1.04 Billion ≈ $152.55 Million |
-0.31% |
| 2017-12-31 | CN¥1.05 Billion ≈ $153.02 Million |
+10.28% |
| 2016-12-31 | CN¥948.21 Million ≈ $138.75 Million |
+21.70% |
| 2015-12-31 | CN¥779.17 Million ≈ $114.02 Million |
-7.59% |
| 2014-12-31 | CN¥843.20 Million ≈ $123.39 Million |
+23.29% |
| 2013-12-31 | CN¥683.92 Million ≈ $100.08 Million |
+17.68% |
| 2012-12-31 | CN¥581.18 Million ≈ $85.04 Million |
+101.73% |
| 2011-12-31 | CN¥288.10 Million ≈ $42.16 Million |
+52.71% |
| 2010-12-31 | CN¥188.65 Million ≈ $27.61 Million |
-40.01% |
| 2009-12-31 | CN¥314.48 Million ≈ $46.02 Million |
+71.23% |
| 2008-12-31 | CN¥183.66 Million ≈ $26.87 Million |
-2.98% |
| 2007-12-31 | CN¥189.30 Million ≈ $27.70 Million |
+11.93% |
| 2006-12-31 | CN¥169.13 Million ≈ $24.75 Million |
-16.84% |
| 2005-12-31 | CN¥203.38 Million ≈ $29.76 Million |
+37.06% |
| 2004-12-31 | CN¥148.38 Million ≈ $21.71 Million |
-21.17% |
| 2003-12-31 | CN¥188.23 Million ≈ $27.54 Million |
+7.98% |
| 2002-12-31 | CN¥174.31 Million ≈ $25.51 Million |
-4.66% |
| 2001-12-31 | CN¥182.84 Million ≈ $26.76 Million |
-- |
About ZhuZhou QianJin Pharmaceutical Co Ltd
ZhuZhou QianJin Pharmaceutical Co.,Ltd researches, develops, produces, and sells traditional Chinese medicines, chemicals and API, and TCM derivatives in China. The company offers TCM products, chemical medicine, derivative products, and hygienic products, including gynaecological and baby nursing, and maternity pad/ maternity package. ZhuZhou QianJin Pharmaceutical Co.,Ltd was founded in 1966 an… Read more